Cefotaxime sodium and Elocon drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported only by a few people who take Cefotaxime sodium and Elocon together.

The phase IV clinical study analyzes what interactions people who take Cefotaxime sodium and Elocon have. It is created by eHealthMe based on reports of 2 people who take the same drugs from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 25, 2022

2 people who take Cefotaxime sodium and Elocon together, and have interactions are studied.


What is Cefotaxime sodium?

Cefotaxime sodium has active ingredients of cefotaxime sodium. eHealthMe is studying from 2,200 Cefotaxime sodium users for its effectiveness, alternative drugs and more.

What is Elocon?

Elocon has active ingredients of mometasone furoate. It is often used in eczema. eHealthMe is studying from 1,831 Elocon users for its effectiveness, alternative drugs and more.

Number of Cefotaxime sodium and Elocon reports submitted per year:

Cefotaxime sodium and Elocon drug interactions.

Common Cefotaxime Sodium and Elocon drug interactions by gender *:

female:

  1. Cystitis
  2. Eye infection
  3. Injection site cyst
  4. Lung infection
  5. Drug effect decreased
  6. Drug ineffective
  7. Fat tissue increased
  8. Hypersensitivity
  9. Injection site mass
  10. Injection site reaction

male:

n/a

Common Cefotaxime Sodium and Elocon drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Cystitis
  2. Eye infection
  3. Injection site cyst
  4. Lung infection
  5. Drug effect decreased
  6. Drug ineffective
  7. Fat tissue increased
  8. Hypersensitivity
  9. Injection site mass
  10. Injection site reaction

60+:

n/a

* Approximation only. Some reports may have incomplete information.

Do you take Cefotaxime sodium and Elocon?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Cefotaxime sodium and Elocon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Cefotaxime sodium interactions:

Browse all interactions between Cefotaxime sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Elocon interactions:

Browse all interactions between Elocon and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cefotaxime sodium and mometasone furoate (the active ingredients of Cefotaxime sodium and Elocon, respectively), and Cefotaxime sodium and Elocon (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Cefotaxime sodium and Elocon.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: